Researchmoz Global Pvt. Ltd.

Generic Drugs Market in Japan to Grow at a CAGR of 8.16% over 2015-2019

ResearchMoz added Latest Research Report titled " Generic Drugs Market in Japan 2015-2019: Worldwide Market Size, Shares, Trends, Growth, Survey and Forecast report " to it's Large Report database.

 

Albany, NY -- (SBWIRE) -- 05/11/2016 -- A generic drug is a duplicate of brand-name drugs and has the same dosage form, active ingredient(s), potency, route of administration, quality, and intended use as that of branded drugs. Generic drugs enter the market once the patent protection of the original developer expires. Generally, the cost of generic drugs is 50-70 percent lower than that of their brand-name counterparts, while meeting the very same standards of safety, quality, and efficacy as the innovator drugs.

The Generic Drugs market in Japan to grow at a CAGR of 8.16 percent over the period 2014-2019. Generic drugs help the manufacturer by eliminating the need to develop and market a new drug. As the patent approaches expiration, manufacturers can apply to the FDA for approval to manufacture and sell generic versions of the drug. Generic drugs are equal to and within the bioequivalence range of branded drugs.

Browse Market info, get a Sample PDF with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=243955

The Generic Drugs market in Japan can be divided into three segments: Generic Prescription Medicines, Super Generics, and Biosimilars. This report covers the present scenario and the growth prospects of the Generic Drugs market in Japan for the period 20152019. To calculate the market size, the report considers the revenue generated from the following segments:

Generic Prescription Medicines
- Super Generics
- Biosimilars

TechNavio's report, the Generic Drugs market in Japan 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape of the Generic Drugs market in Japan and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Vendors
- Meiji Seika Pharma
- Nichi-Iko Pharmaceutical
- Nipro Pharma
- Sawai Pharmaceuticals
- Teva Pharmaceutical Industries
- Towa Pharmaceutical

Other Prominent Vendors
- Actavis
- Daiichi Sankyo
- Daito Pharmaceutical
- Eisai
- Fuji Pharma
- GlaxoSmithKline
- Hikari Pharmaceutical
- Hospira

Enquiry at: http://www.researchmoz.us/enquiry.php?type=E&repid=243955

Key Questions Answered in this Report:-

- What will the market size be in 2019 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

About ResearchMoz
ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:
Mr. Nachiket
Albany NY - 12207
United States
Tel: +1-518-621-2074
Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Latest Press-Releases: http://www.researchmoz.us/pressrelease